These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration. Lee JY; Chung H; Kim HC Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799 [TBL] [Abstract][Full Text] [Related]
5. Focal choroidal excavation complicated by choroidal neovascularization. Xu H; Zeng F; Shi D; Sun X; Chen X; Bai Y Ophthalmology; 2014 Jan; 121(1):246-250. PubMed ID: 24095605 [TBL] [Abstract][Full Text] [Related]
6. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization. Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal ziv-aflibercept for the treatment of choroidal neovascularisation associated with conditions other than age-related macular degeneration. Braimah IZ; Stewart M; Videkar C; Dedhia CJ; Chhablani J; Br J Ophthalmol; 2017 Sep; 101(9):1201-1205. PubMed ID: 28119292 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical correlates of focal choroidal excavation in eyes with age-related macular degeneration, polypoidal choroidal vasculopathy and central serous chorioretinopathy. Lim FP; Wong CW; Loh BK; Chan CM; Yeo I; Lee SY; Mathur R; Wong D; Wong TY; Cheung CM Br J Ophthalmol; 2016 Jul; 100(7):918-923. PubMed ID: 26504178 [TBL] [Abstract][Full Text] [Related]
12. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY. Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691 [TBL] [Abstract][Full Text] [Related]
13. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections. Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476 [TBL] [Abstract][Full Text] [Related]
14. Choroidal Neovascularization Is Common in Best Vitelliform Macular Dystrophy and Plays a Role in Vitelliform Lesion Evolution. Han IC; Coussa RG; Mansoor M; Critser DB; Sohn EH; Russell JF; Stone EM Ophthalmol Retina; 2023 May; 7(5):441-449. PubMed ID: 36528270 [TBL] [Abstract][Full Text] [Related]
15. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES IN DIFFERENT STAGES OF BEST VITELLIFORM MACULAR DYSTROPHY. Battaglia Parodi M; Iacono P; Romano F; Bandello F Retina; 2018 May; 38(5):1041-1046. PubMed ID: 28376040 [TBL] [Abstract][Full Text] [Related]
16. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION. Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235 [TBL] [Abstract][Full Text] [Related]
17. Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation. Lee CS; Woo SJ; Kim YK; Hwang DJ; Kang HM; Kim H; Lee SC Ophthalmology; 2014 May; 121(5):1029-35. PubMed ID: 24439757 [TBL] [Abstract][Full Text] [Related]
18. Choroidal thickness and visual prognosis in type 1 lesion due to neovascular age-related macular degeneration. Hernández-Martínez P; Dolz-Marco R; Hervás-Marín D; Andreu-Fenoll M; Gallego-Pinazo R; Arévalo JF Eur J Ophthalmol; 2017 Mar; 27(2):196-200. PubMed ID: 27646337 [TBL] [Abstract][Full Text] [Related]
20. Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report. Liu Y; Wang X; Zhu M; Xu G; Li L BMC Ophthalmol; 2019 Mar; 19(1):68. PubMed ID: 30849939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]